CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice

被引:13
|
作者
van Puijvelde, Gijs H. M. [1 ]
Foks, Amanda C. [1 ]
van Bochove, Rosemarie E. [1 ]
Bot, Ilze [1 ]
Habets, Kim L. L. [1 ]
de Jager, Saskia C. [1 ]
ter Borg, Mariette N. D. [1 ]
van Osch, Puck [1 ]
Boon, Louis [2 ]
Vos, Mariska [3 ]
de Waard, Vivian [3 ]
Kuiper, Johan [1 ]
机构
[1] Leiden Univ, Leiden Acad, Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands
[2] Bioceros BV, Utrecht, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands
来源
PLOS ONE | 2018年 / 13卷 / 01期
关键词
SMOOTH-MUSCLE-CELLS; KILLER T-CELLS; ANGIOTENSIN-II; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; ATHEROSCLEROTIC LESIONS; ALTERNATIVE ACTIVATION; IMMUNE-RESPONSES; DENDRITIC CELLS; MURINE MODEL;
D O I
10.1371/journal.pone.0190962
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
An abdominal aortic aneurysm (AAA) is a dilatation of the abdominal aorta leading to serious complications and mostly to death. AAA development is associated with an accumulation of inflammatory cells in the aorta including NKT cells. An important factor in promoting the recruitment of these inflammatory cells into tissues and thereby contributing to the development of AAA is angiotensin II (Ang II). We demonstrate that a deficiency in CD1d dependent NKT cells under hyperlipidemic conditions (LDLr-/- CD1d(-/-) mice) results in a strong decline in the severity of angiotensin II induced aneurysm formation when compared with LDLr-/- mice. In addition, we show that Ang II amplifies the activation of NKT cells both in vivo and in vitro. We also provide evidence that type I NKT cells contribute to AAA development by inducing the expression of matrix degrading enzymes in vSMCs and macrophages, and by cytokine dependently decreasing vSMC viability. Altogether, these data prove that CD1d dependent NKT cells contribute to AAA development in the Ang II-mediated aneurysm model by enhancing aortic degradation, establishing that therapeutic applications which target NKT cells can be a successful way to prevent AAA development.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] CD1d Modulates Colonic Inflammation in NOD2-/- Mice by Altering the Intestinal Microbial Composition Comprising Acetatifactor muris
    Lee, Chansu
    Hong, Sung Noh
    Paik, Nam Young
    Kim, Tae Jun
    Kim, Eun Ran
    Chang, Dong Kyung
    Kim, Young-Ho
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (08) : 1081 - 1091
  • [42] Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor-Knockout Mice
    Takai, Shinji
    Jin, Denan
    Yamamoto, Daisuke
    Li, Zhong-Lian
    Otsuki, Yoshinori
    Miyazaki, Mizuo
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 123 (02) : 185 - 194
  • [43] Ig-Like Transcript 4 Inhibits Lipid Antigen Presentation through Direct CD1d Interaction
    Li, Demin
    Wang, Lili
    Yu, Li
    Freundt, Eric C.
    Jin, Boquan
    Screaton, Gavin R.
    Xu, Xiao-Ning
    JOURNAL OF IMMUNOLOGY, 2009, 182 (02) : 1033 - 1040
  • [44] FcγRIIB Inhibits the Development of Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
    Zhao, Ming
    Wigren, Maria
    Duner, Pontus
    Kolbus, Daniel
    Olofsson, Katarina E.
    Bjorkbacka, Harry
    Nilsson, Jan
    Fredrikson, Gunilla Nordin
    JOURNAL OF IMMUNOLOGY, 2010, 184 (05) : 2253 - 2260
  • [45] Development of α-GalCer Analogues with an α-Fluorocarbonyl Moiety as Th2-Selective Ligands of CD1d
    Kim, Hyunsoo
    Song, Heebum
    Park, Jun-Gyu
    Lee, Dong-Sup
    Park, Seung Bum
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (05): : 773 - 779
  • [46] Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5+ B cell expansion
    Palmer, Victoria L.
    Nganga, Vincent K.
    Rothermund, Mary E.
    Perry, Greg A.
    Swanson, Patrick C.
    BMC IMMUNOLOGY, 2015, 16
  • [47] Deficiency of Tissue Factor in Vascular Smooth Muscle Cells is Associated With Increased Development of Angiotensin II-induced Abdominal Aortic Aneurysms
    Owens, A. Phillip, III
    Rateri, Debra L.
    Miller, Christine
    Daugherty, Alan
    Taubman, Mark B.
    Mackman, Nigel
    CIRCULATION, 2013, 128 (22)
  • [48] Involvement of Vascular Angiotensin II-Forming Enzymes in the Progression of Aortic Abdominal Aneurysms in Angiotensin II-Infused ApoE-Deficient Mice
    Inoue, Nao
    Muramatsu, Michiko
    Jin, Denan
    Takai, Shinji
    Hayashi, Tetsuya
    Katayama, Hiroshi
    Kitaura, Yasushi
    Tamai, Hiroshi
    Miyazaki, Mizuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (03) : 164 - 171
  • [49] Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development
    Zheng, Qiuxian
    Xue, Chen
    Gu, Xinyu
    Shan, Dandan
    Chu, Qingfei
    Wang, Jing
    Zhu, Haihong
    Chen, Zhi
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [50] The lysophospholipid-binding molecule CD1D is not required for the alloimmunization response to fresh or stored RBCs in mice despite RBC storage driving alterations in lysophospholipids
    Medved, Jelena
    Knott, Brittney M.
    Tarrah, Soraya N.
    Li, Andria N.
    Shah, Neha
    Moscovich, Tamara C.
    Boscia, Alexis R.
    Salazar, Juan E.
    Santhanakrishnan, Manjula
    Hendrickson, Jeanne E.
    Fu, Xiaoyun
    Zimring, James C.
    Luckey, Chance John
    TRANSFUSION, 2021, 61 (07) : 2169 - 2178